메뉴 건너뛰기




Volumn 56, Issue 9, 2013, Pages 1340-1343

Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts ≥300 cells/μL and HIV-1 suppression?

Author keywords

CD4; CD4 count; HIV load; HIV suppression; HIV 1 RNA

Indexed keywords

INTERFERON; STEROID;

EID: 84875971238     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit004     Document Type: Article
Times cited : (82)

References (12)
  • 1
    • 0037072066 scopus 로고    scopus 로고
    • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies
    • DOI 10.1016/S0140-6736(02)09411-4
    • Egger M, May M, Chêne G, et al. ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-29. (Pubitemid 34786200)
    • (2002) Lancet , vol.360 , Issue.9327 , pp. 119-129
    • Egger, M.1    May, M.2    Chene, G.3    Phillips, A.N.4    Ledergerber, B.5    Dabis, F.6    Costagliola, D.7
  • 2
    • 67649573353 scopus 로고    scopus 로고
    • Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents Available at Accessed 13 September 2012
    • Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services 2012. Available at: http://www.aidsinfo. nih.gov/guidelines/. Accessed 13 September 2012.
    • Department of Health and Human Services 2012
  • 3
    • 65549121051 scopus 로고    scopus 로고
    • Centers for disease control and prevention (CDC); National institutes of health; HIV medicine association of the infectious diseases society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV medicine association of the infectious diseases society of America
    • Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4):1-207.
    • (2009) MMWR Recomm Rep , vol.58 , Issue.RR-4 , pp. 1-207
    • Kaplan, J.E.1    Benson, C.2    Holmes, K.H.3    Brooks, J.T.4    Pau, A.5    Masur, H.6
  • 4
    • 84875984635 scopus 로고    scopus 로고
    • Lymphocytic series
    • Leukocyte differential count: diagnostic information and inferences In Wu A, ed. Philadelphia: W. B. Saunders Company
    • Leukocyte differential count: diagnostic information and inferences. Lymphocytic series. In: Wu A, ed. Tietz clinical guide to laboratory tests. Philadelphia: W. B. Saunders Company, 2006: 1194-5.
    • (2006) Tietz Clinical Guide to Laboratory Tests , pp. 1194-1195
  • 6
    • 0029420588 scopus 로고
    • Product-limit survival functions with correlated survival times
    • Williams RL. Product-limit survival functions with correlated survival times. Lifetime Data Anal 1995; 1: 171-86.
    • (1995) Lifetime Data Anal , vol.1 , pp. 171-186
    • Williams, R.L.1
  • 7
    • 0002889725 scopus 로고
    • Cox-type regression analysis for large numbers of small groups of correlated failure time observations
    • In Klein JP, Goel PK, ed. Dordrecht: Kluwer Academic Publishers
    • Lee EW, Wei LJ, Amato DA. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, ed. Survival analysis: state of the art. Dordrecht: Kluwer Academic Publishers, 1992: 237-47.
    • (1992) Survival Analysis: State of the Art , pp. 237-247
    • Lee, E.W.1    Wei, L.J.2    Amato, D.A.3
  • 9
    • 0025091878 scopus 로고
    • Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: Total lymphocyte count fluctuations and diurnal cycle are important
    • Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3:144-51. (Pubitemid 20080777)
    • (1990) Journal of Acquired Immune Deficiency Syndromes , vol.3 , Issue.2 , pp. 144-151
    • Malone, J.L.1    Simms, T.E.2    Gray, G.C.3    Wagner, K.F.4    Burge, J.R.5    Burke, D.S.6
  • 10
    • 77955670919 scopus 로고    scopus 로고
    • ICONA Foundation Study. Rate of CD4+ cell count increase over periods of viral load suppression: Relationship with the number of previous virological failures
    • Trotta MP, Cozzi-Lepri A, Ammassari A, et al; ICONA Foundation Study. Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. Clin Infect Dis 2010; 51:456-64.
    • (2010) Clin Infect Dis , vol.51 , pp. 456-464
    • Trotta, M.P.1    Cozzi-Lepri, A.2
  • 11
    • 77955699108 scopus 로고    scopus 로고
    • CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection
    • Maggiolo F, Leone S. CD4+ T lymphocyte recovery in individuals with type 1 human immunodeficiency virus infection. Clin Infect Dis 2010; 51:465-7.
    • (2010) Clin Infect Dis , vol.51 , pp. 465-467
    • Maggiolo, F.1    Leone, S.2
  • 12
    • 77955836995 scopus 로고    scopus 로고
    • Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count 200 cells/μL?
    • The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE)
    • The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count
    • (2010) Clin Infect Dis , vol.51 , pp. 611-619


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.